Abraham Pinter
14Patents
6h-index
14Co-inventors
63Inventor score
Filing activity: Dec 28, 1978 → Jun 15, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6815201B2 | HIV-1 gp120 V1/V2 domain epitopes capable of generating neutralizing antibodies | Chemistry; Metallurgy | 72 | Expired |
| US5616459A | Selection of ribozymes that efficiently cleave target RNA | Chemistry; Metallurgy | 35 | Expired |
| US5643756A | Fusion glycoproteins | Chemistry; Metallurgy | 27 | Expired |
| US5952474A | Fusion glycoproteins | Chemistry; Metallurgy | 21 | Expired |
| US4406885A | Preparation of native oncornavirus envelope subunits and vaccines therefrom | Emerging Cross-Sectional Technologies | 11 | Expired |
| US5922325A | Synergistic neutralization of HIV-1 by human monoclonal antibodies and other antibodies directed against the v3 loop and the CD-4 binding site of GP-120,and the use for immunotherapy of HIV-1 infection | Chemistry; Metallurgy | 10 | Expired |
| US10729771B2 | Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of Mycobacterium tuberculosis infections | Physics | 1 | Active |
| US11273220B2 | Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of Mycobacterium tuberculosis infections | Physics | 1 | Active |
| US12303562B2 | Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of Mycobacterium tuberculosis infections | Physics | 0 | Active |
| US8475799B2 | HIV-1 GP41 neutralization domain and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11707525B2 | Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of Mycobacterium tuberculosis infections | Physics | 0 | Active |
| US8961987B2 | Immunogen comprising the HIV GP120 V3 loop in a conformation that induces broadly neutralizing antibodies | Chemistry; Metallurgy | 0 | Active |
| US9796773B2 | Neutralizing antibodies that bind to the HIV-1 Env V2 critical neutralization domain | Chemistry; Metallurgy | 0 | Active |
| US9938325B2 | HIV-1 antigens with discrete conformational forms in the V1/V2 domain and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.